Search Results for 'Cancer-Nsclc'

Cancer-Nsclc published presentations and documents on DocSlides.

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

by stefany-barnette

Renato G. Martins, MD, MPH. Medical Director, Tho...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

by debby-jeon

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

by sawyer742

Intervista a Federico . Cappuzzo. Background:. Pr...

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

by everly

Professor Rachel Butler. The genomic complexity of...

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

by sherrill-nordquist

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

by ellena-manuel

Jared Weiss, MD . Assistant . Professor of Medici...

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer

by oconnor

. 5. th. most commonly diagnosed cancer in Austra...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

by elena

Kamil Konopka. Department of Oncology, University ...

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

by scarlett

NSCLC, non-small cell lung cancer.. Lung cancer in...

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

by southan

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...

Consensus or Controversy?

Consensus or Controversy?

by okelly

Addressing Practical Clinical Questions Across the...

Beth Sandy, MSN, CRNP Nurse Practitioner

Beth Sandy, MSN, CRNP Nurse Practitioner

by PriceOfFreedom

Abramson Cancer Center . University of Pennsylvani...

Please note, these are the

Please note, these are the

by disclaimercanon

actual. . video-recorded proceedings from the . l...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

by stefany-barnette

The Cancer genome atlas (TCGA) and the search for...

by jane-oiler

of the expression of . 17-beta-hydroxysteroid . ...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

by ellena-manuel

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

by luanne-stotts

Brada. . Torino. . 6 March 2015. Perspectives...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

by debby-jeon

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

by alida-meadow

Gandara. , MD. University of California, Davis . ...

by cheryl-pisano

Le Chevalier, . MD. The Role of Translational Res...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by chaptoe

proceedings from the live CME event and may includ...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

by luanne-stotts

The Role of Antiangiogenic Agents in the Changin...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

by pasty-toler

This program will include a discussion of off-lab...

by pasty-toler

MD. The Evolving Treatment Landscape in NSCLC: Co...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

by test

Intervista a Federico . Cappuzzo. Background:. P...

ALK in lung cancer: Past, present, and future

ALK in lung cancer: Past, present, and future

by belinda

Gene Mutations in Lung . Adenocarcinomas. 17 years...

Small cell lung cancer (SCLC):

Small cell lung cancer (SCLC):

by faith

an . introduction. Last updated: . July . 2020. In...

Lung cancer Treatment

Lung cancer Treatment

by attentionallianz

Consequences of the Lack of Patients of color &...

by lorenzo155

4/1/24. Michael Forte, MD. Outline . Lung Cancer ...

INTRODUCTION RESULTS

INTRODUCTION RESULTS

by arjun383

Mason Alford, MSc. a. , . Candace J. Grisham, MS. ...

Updates in the systemic treatment for lung

Updates in the systemic treatment for lung

by madeline

cancer: Immunotherapy. Oscar Arrieta MD. Thoracic....

Checkpoint inhibitors for

Checkpoint inhibitors for

by paisley

NSCLC. An update. Solange Peters, MD-PhD. Oncology...

cell lung cancer NSCLCESMO Clinical Practice Guidelines for diagnosi

cell lung cancer NSCLCESMO Clinical Practice Guidelines for diagnosi

by adia

RecommendationLoE, GoRScreening with LDCT (low-dos...

mRNA anticancer Vaccines

mRNA anticancer Vaccines

by byrne

breakthrough. . approach. in . cancer. . treatm...

Targeting KRAS G12C in Solid Tumors

Targeting KRAS G12C in Solid Tumors

by morton

: . A . New Anticancer Approach . Marwan Fakih, ...

NSCLC: Staging and TNM classification

NSCLC: Staging and TNM classification

by molly

NSCLC, non-small cell lung cancer; TNM. , tumour, ...

Instructions for Use of These Slides

Instructions for Use of These Slides

by carla

The purpose of these slides is to serve as a resou...

OMICS International welcomes submissions that are original and technically so as to serve both th

OMICS International welcomes submissions that are original and technically so as to serve both th

by lois-ondreau

OMICS Journals are poised in excellence by publi...

Slides last updated:

Slides last updated:

by stefany-barnette

October 2013 . Ferlay . J, Shin HR, Bray F, Forma...

Slides last updated:

Slides last updated:

by calandra-battersby

October 2013. There are two main types of lung . ...